• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型细胞因子血液吸附系统对胰头切除术后感染性休克炎症反应的影响——病例报告

Effects of a novel cytokine haemoadsorbtion system on inflammatory response in septic shock after cephalic pancreatectomy - a case report.

作者信息

Tomescu Dana, Dima Simona O, Tănăsescu Sabina, Tănase Cristiana Pistol, Năstase Anca, Popescu Mihai

机构信息

Department of Anaesthesiology and Critical Care III, Fundeni Clinical Institute, Bucharest, Romania.

"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

出版信息

Rom J Anaesth Intensive Care. 2014 Oct;21(2):134-138.

PMID:28913446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5505352/
Abstract

Severe sepsis and septic shock are associated with an inflammatory cascade that is primarily responsible for multiple organ dysfunction. To date, there are no specific treatments designed to modulate and rebalance inflammatory cytokines levels. We present a case of a 50 years old man with postoperative septic shock after undergoing cephalic pancreatectomy for a pancreatic cystic tumor. The use of a haemoadsorbtion device (CytoSorb) in combination with continuous veno-venous haemofiltration was associated with a decrease in TNFα, IL-1β and IFNγ and an increase in IL-10 levels measured before and after two consecutive procedures. The effect of CytoSorb on inflammatory cytokines translated into a more stable haemodynamic profile with a stable cardiac output and normalization of systemic vascular resistance index and decreased vasopressor requirements. Further prospective large clinical trials are required in order to determine the indications for CytoSorb and to evaluate the overall outcome.

摘要

严重脓毒症和脓毒性休克与一种炎症级联反应相关,该反应是导致多器官功能障碍的主要原因。迄今为止,尚无旨在调节和重新平衡炎症细胞因子水平的特异性治疗方法。我们报告一例50岁男性患者,其因胰腺囊性肿瘤接受胰头全切除术后发生脓毒性休克。使用血液吸附装置(CytoSorb)联合持续静脉-静脉血液滤过,与连续两次治疗前后测得的肿瘤坏死因子α(TNFα)、白细胞介素-1β(IL-1β)和干扰素γ(IFNγ)水平降低以及白细胞介素-10(IL-10)水平升高相关。CytoSorb对炎症细胞因子的作用转化为更稳定的血流动力学状态,心输出量稳定,全身血管阻力指数正常化,血管升压药需求减少。需要进一步开展前瞻性大型临床试验,以确定CytoSorb的适应证并评估总体结局。

相似文献

1
Effects of a novel cytokine haemoadsorbtion system on inflammatory response in septic shock after cephalic pancreatectomy - a case report.新型细胞因子血液吸附系统对胰头切除术后感染性休克炎症反应的影响——病例报告
Rom J Anaesth Intensive Care. 2014 Oct;21(2):134-138.
2
Changes in Cytokines, Haemodynamics and Microcirculation in Patients with Sepsis/Septic Shock Undergoing Continuous Renal Replacement Therapy and Blood Purification with CytoSorb.细胞因子、血流动力学和微循环变化在接受连续肾脏替代治疗和细胞因子吸附血液净化的脓毒症/脓毒性休克患者中。
Blood Purif. 2020;49(1-2):107-113. doi: 10.1159/000502540. Epub 2019 Aug 21.
3
Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial.细胞因子清除术联合 CytoSorb® 在心脏手术中的应用:一项前瞻性随机对照试验。
Crit Care. 2019 Apr 3;23(1):108. doi: 10.1186/s13054-019-2399-4.
4
First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: a case report.体外膜肺氧合(ECMO)与细胞因子清除疗法在心源性脓毒性休克中的首次成功联合应用:一例病例报告
Int J Artif Organs. 2015 Feb;38(2):113-6. doi: 10.5301/ijao.5000382. Epub 2015 Feb 3.
5
Use of a novel hemoadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multi-organ dysfunction: A case study.新型血液吸附装置用于清除细胞因子作为多器官功能障碍的感染性休克患者辅助治疗的病例研究
Indian J Crit Care Med. 2014 Dec;18(12):822-4. doi: 10.4103/0972-5229.146321.
6
Hemoadsorption by CytoSorb in septic patients: a case series.细胞吸附剂(CytoSorb)对脓毒症患者的血液吸附:病例系列
Crit Care. 2017 Mar 27;21(1):74. doi: 10.1186/s13054-017-1662-9.
7
Successful use of CytoSorb in a Covid-19 patient with secondary septic shock due to a sacral decubitus infection.成功使用 CytoSorb 治疗因骶尾部褥疮感染导致的继发感染性休克的 COVID-19 患者。
Int J Artif Organs. 2021 Dec;44(12):1034-1038. doi: 10.1177/03913988211016473. Epub 2021 May 16.
8
CytoSorb, a novel therapeutic approach for patients with septic shock: a case report.细胞吸附疗法——脓毒性休克患者的一种新型治疗方法:一例病例报告
Int J Artif Organs. 2015 Aug;38(8):461-4. doi: 10.5301/ijao.5000429. Epub 2015 Aug 31.
9
Septic shock secondary to β-hemolytic streptococcus-induced necrotizing fasciitis treated with a novel cytokine adsorption therapy.采用新型细胞因子吸附疗法治疗β溶血性链球菌引起的坏死性筋膜炎继发的感染性休克。
Int J Artif Organs. 2014 May;37(5):422-6. doi: 10.5301/ijao.5000315. Epub 2014 Apr 17.
10
Continuous hemoadsorption with a cytokine adsorber during sepsis - a review of the literature.脓毒症期间使用细胞因子吸附器进行持续血液吸附——文献综述
Int J Artif Organs. 2017 May 29;40(5):205-211. doi: 10.5301/ijao.5000591. Epub 2017 May 19.

引用本文的文献

1
Revolutionizing Severe Malaria Management: The Role of CytoSorb® Hemoadsorption in Treating Malaria-Induced Liver Dysfunction.革新重症疟疾管理:CytoSorb®血液吸附在治疗疟疾诱导的肝功能障碍中的作用
Cureus. 2025 Jan 20;17(1):e77696. doi: 10.7759/cureus.77696. eCollection 2025 Jan.
2
Use of CytoSorb® hemoadsorption column during prolonged cardiopulmonary bypass in complex cardiac surgery patient.在复杂心脏手术患者长时间体外循环期间使用 CytoSorb® 血液吸附柱。
J Cardiothorac Surg. 2022 Jul 7;17(1):172. doi: 10.1186/s13019-022-01922-7.
3
Hemoadsorption in 'Liver Indication'-Analysis of 109 Patients' Data from the CytoSorb International Registry.“肝脏适应症”中的血液吸附——来自CytoSorb国际注册中心109例患者数据的分析
J Clin Med. 2021 Nov 5;10(21):5182. doi: 10.3390/jcm10215182.
4
Adsorption therapy in critically ill with septic shock and acute kidney injury: a retrospective and prospective cohort study.脓毒性休克和急性肾损伤重症患者的吸附治疗:一项回顾性和前瞻性队列研究。
Ann Intensive Care. 2020 Nov 18;10(1):154. doi: 10.1186/s13613-020-00772-7.
5
Biomarkers of sepsis, a never-ending story.脓毒症的生物标志物,一个永无止境的故事。
Rom J Anaesth Intensive Care. 2014 Oct;21(2):83-85.

本文引用的文献

1
Septic shock secondary to β-hemolytic streptococcus-induced necrotizing fasciitis treated with a novel cytokine adsorption therapy.采用新型细胞因子吸附疗法治疗β溶血性链球菌引起的坏死性筋膜炎继发的感染性休克。
Int J Artif Organs. 2014 May;37(5):422-6. doi: 10.5301/ijao.5000315. Epub 2014 Apr 17.
2
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.脓毒症导致的免疫抑制:从细胞功能障碍到免疫治疗。
Nat Rev Immunol. 2013 Dec;13(12):862-74. doi: 10.1038/nri3552. Epub 2013 Nov 15.
3
Improvement of hemodynamic and inflammatory parameters by combined hemoadsorption and hemodiafiltration in septic shock: a case report.血液吸附联合血液透析滤过改善感染性休克患者的血流动力学和炎症指标:1例病例报告
Blood Purif. 2013;35(4):314-5. doi: 10.1159/000351206. Epub 2013 Jul 31.
4
Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies.监测脓毒症中的免疫反应:免疫佐剂治疗给药的合理方法。
Curr Opin Immunol. 2013 Aug;25(4):477-83. doi: 10.1016/j.coi.2013.05.006. Epub 2013 May 28.
5
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.拯救脓毒症运动:严重脓毒症和脓毒性休克管理国际指南,2012 年。
Intensive Care Med. 2013 Feb;39(2):165-228. doi: 10.1007/s00134-012-2769-8. Epub 2013 Jan 30.
6
Current trends in inflammatory and immunomodulatory mediators in sepsis.脓毒症中炎症和免疫调节介质的当前趋势。
J Leukoc Biol. 2013 Mar;93(3):329-42. doi: 10.1189/jlb.0912437. Epub 2012 Nov 7.
7
Sepsis in general surgery: the 2005-2007 national surgical quality improvement program perspective.普通外科中的脓毒症:2005 - 2007年国家外科质量改进计划视角
Arch Surg. 2010 Jul;145(7):695-700. doi: 10.1001/archsurg.2010.107.
8
Postoperative sepsis in the United States.美国术后脓毒症。
Ann Surg. 2010 Dec;252(6):1065-71. doi: 10.1097/SLA.0b013e3181dcf36e.
9
Sepsis syndromes: understanding the role of innate and acquired immunity.脓毒症综合征:了解先天性免疫和获得性免疫的作用。
Shock. 2001 Aug;16(2):83-96. doi: 10.1097/00024382-200116020-00001.
10
Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis.抗白细胞介素-12疗法可保护小鼠免受致死性内毒素血症的影响,但会损害小鼠大肠杆菌腹膜炎性败血症中的细菌清除能力。
Shock. 1997 Nov;8(5):349-56. doi: 10.1097/00024382-199711000-00006.